Purple Biotech Ltd. ADR diskutieren
Purple Biotech Ltd. ADR
WKN: A2QLTP / Symbol: PPBT / Name: Purple Biotech / Aktie / Biotechnologie & medizinische Forschung / Micro Cap /
0,32 €
-1,86 %
Purple Biotech Ltd. (NASDAQ: PPBT) is now covered by analysts at Jonestrading. They set a "buy" rating and a $8.00 price target on the stock.
Ratings data for PPBT provided by MarketBeat
Purple Biotech Ltd. (NASDAQ: PPBT) had its price target raised by analysts at HC Wainwright from $9.00 to $10.00. They now have a "buy" rating on the stock.
Ratings data for PPBT provided by MarketBeat
Purple Biotech Ltd. (NASDAQ: PPBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for PPBT provided by MarketBeat
Purple Biotech Ltd. (NASDAQ: PPBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for PPBT provided by MarketBeat
Purple Biotech Ltd. (NASDAQ: PPBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for PPBT provided by MarketBeat
Purple Biotech Ltd (NASDAQ: PPBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for PPBT provided by MarketBeat
Purple Biotech Ltd (NASDAQ: PPBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for PPBT provided by MarketBeat
Purple Biotech Ltd (NASDAQ: PPBT) had its price target lowered by analysts at HC Wainwright from $10.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for PPBT provided by MarketBeat
Purple Biotech Ltd (NASDAQ: PPBT) had its price target raised by analysts at HC Wainwright from $8.00 to $33.00. They now have a "buy" rating on the stock.
Ratings data for PPBT provided by MarketBeat
Neueste Beiträge
B__Riley in Matthews International Corp. diskutieren